Ondansetron dosing in pediatric gastroenteritis: a prospective cohort, dose-response study.
Freedman
Stephen B
SB
Division of Pediatric Emergency Medicine, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
Powell
Elizabeth C
EC
Nava-Ocampo
Alejandro A
AA
Finkelstein
Yaron
Y
D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003681:Dehydration / Q000188:drug therapy / Q000209:etiology; D003967:Diarrhea / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D005260:Female; D005440:Fluid Therapy; D005759:Gastroenteritis / Q000503:physiopathology*; D006801:Humans; D007223:Infant; D007262:Infusions, Intravenous; D008297:Male; D017294:Ondansetron / Q000008:administration & dosage* / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use; D016896:Treatment Outcome; D014839:Vomiting / Q000209:etiology / Q000517:prevention & control*
D012702:Serotonin Antagonists; D017294:Ondansetron